From SBA 7(a) loans to seller notes, understand the capital stack options available to physician buyers and investors acquiring dermatology practices in the $1M–$5M revenue range.
Dermatology practices are among the most financeable medical specialties due to predictable recurring revenue, strong EBITDA margins, and dual income streams from both insurance-reimbursed medical services and high-margin cash-pay cosmetics. Lenders favor practices with diversified payer mixes, 2+ licensed providers, and documented patient volume. Most acquisitions in the $2M–$8M purchase price range are structured using SBA 7(a) loans as the primary debt instrument, supplemented by seller notes and occasionally equity from PE-backed platforms or physician investors.
The most common financing tool for independent buyers acquiring dermatology practices. SBA 7(a) loans cover up to 90% of the purchase price, making them ideal for physician entrepreneurs with limited upfront capital.
Pros
Cons
The selling physician defers a portion of the purchase price, typically 10–20%, structured as a promissory note. Often paired with SBA financing to bridge valuation gaps or reduce buyer cash requirements at close.
Pros
Cons
PE-backed dermatology roll-up platforms or physician investment groups contribute equity capital in exchange for ownership stakes, typically paired with institutional debt financing for larger platform acquisitions.
Pros
Cons
$4,500,000 (dermatology practice at 5x EBITDA on $900,000 EBITDA)
Purchase Price
~$42,000/month combined (SBA loan ~$38,000 + seller note ~$4,000 at 6% over 5 years)
Monthly Service
Approximately 1.45x DSCR at $900,000 EBITDA; above the 1.25x minimum threshold most SBA lenders require for healthcare practice loans
DSCR
SBA 7(a) Loan: $3,600,000 (80%) | Seller Note: $450,000 (10%) | Buyer Equity/Down Payment: $450,000 (10%)
Yes. SBA 7(a) loans are compatible with MSO structures commonly used in dermatology to comply with corporate practice of medicine laws, provided the MSO and PC are properly structured and disclosed to the lender.
Most SBA lenders require minimum $300,000–$400,000 in adjusted EBITDA and a debt service coverage ratio of at least 1.25x after accounting for owner compensation and all debt obligations.
Lenders often apply a haircut to cosmetic revenue due to its discretionary nature. Practices with more than 50% cosmetic revenue may face tighter scrutiny or require larger down payments to offset perceived income volatility.
Not always, but SBA lenders frequently require a seller note of 10–15% when the practice's goodwill is primarily physician-dependent, ensuring the seller has financial incentive to support a successful ownership transition.
More Dermatology Practice Guides
DealFlow OS surfaces acquisition targets and helps you structure the deal. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers